NCT01827137 2024-09-19WT1 Vaccine Treatment of Patients With Multiple Myeloma After Autologous Stem Cell TransplantationSellas Life Sciences GroupPhase 1/2 Completed20 enrolled 9 charts
NCT00064610 2008-02-11Phase I/II Dose Escalation Study of VELCADE® and Docetaxel in Patients With Advanced Androgen-Independent Prostate CancerMillennium Pharmaceuticals, Inc.Phase 1/2 Completed102 enrolled